| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 21, 2020Company Actively Supporting Its Employees, Customers, and Communities
DUBLIN, April 21, 2020 (GLOBE NEWSWIRE) -- Ahead of the end of its fiscal fourth quarter of fiscal year 2020, Medtronic plc (NYSE:MDT) today provided an update on its response to the COVID-19...
-
Apr 8, 2020FDA Authorizes Use of PB560 in the United States
DUBLIN, April 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced updates regarding its efforts to increase ventilator production around...
-
Mar 30, 2020
DUBLIN, March 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it is publicly sharing the design specifications for the Puritan...
-
Mar 30, 2020First Study in the U.S. and Japan to Report Results on One-Month DAPT Duration in High Bleeding Risk Patients with Current-Generation DES
DUBLIN, March 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced positive results of the Onyx ONE Clear Study that evaluated Resolute Onyx DES in high bleeding risk (HBR)...
-
Mar 29, 2020ACC.20/WCC: Low Rates of Paravalvular Leak and High Survival Observed in Late-breaking Clinical Trial of Low-Risk Bicuspid Aortic Stenosis Patients
DUBLIN, March 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced late-breaking clinical data from the Low Risk Bicuspid Study assessing...
-
Mar 29, 2020ACC.20/WCC: Study Finds Significant Blood Pressure Reductions Achieved with RDN in Absence of Anti-Hypertensive Medication
DUBLIN, March 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first-ever clinical data from the SPYRAL HTN-OFF MED Pivotal Trial....
-
Mar 29, 2020
DUBLIN, March 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) issued the following statement regarding a New York Times article mentioning Medtronic on March 29, 2020: Medtronic seeks to...
-
Mar 27, 2020New Offerings Available to Existing Medtronic Care Management Services Customers as well as New Hospital Systems, Health Plans and Employers
DUBLIN, March 27, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its Medtronic Care Management Services (MCMS) business is launching...
-
Mar 25, 2020Donation is Focused on Supporting and Equipping Frontline Health Workers Globally and Investing in Responsive Local Efforts that Assist Vulnerable Populations
DUBLIN and MINNEAPOLIS, March 25, 2020 (GLOBE NEWSWIRE) -- The Medtronic Foundation announced an additional $10M in contributions to COVID-19 relief efforts across the globe. This adds to the...
-
Mar 18, 2020
DUBLIN, March 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, continues to make progress in increasing ventilator production worldwide. The company...
-
Mar 9, 2020
(NYSE:MDT) on Friday, March 6, 2020, approved the fiscal year 2020 fourth quarter cash dividend of $0.54 per ordinary share, representing an 8 percent increase over the prior year. This quarterly...
-
Mar 9, 2020
DUBLIN, March 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the virtual Barclays Global Healthcare...
-
Mar 3, 2020
DUBLIN, March 03, 2020 (GLOBE NEWSWIRE) -- Coinciding with World Obesity Day, Medtronic further demonstrated its ongoing commitment to increasing patient access to quality care by taking the...
-
Feb 25, 2020
DUBLIN, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 40th Annual Cowen and Company Healthcare...
-
Feb 24, 2020Positive Data on Many Medtronic Innovations Presented at ATTD: Extended Wear Infusion Set Designed to Last Twice as Long, MiniMed™ 670G System Real-Life Performance in Europe, and ProCGM Use in Type 2 Diabetes Patients
DUBLIN, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a successful conclusion to the 13th International Conference on...
-
Feb 24, 2020
DUBLIN, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, is hiring its first Chief Inclusion and Diversity Officer, underscoring its continued...
-
Feb 19, 2020
DUBLIN, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 9th Annual SVB Leerink Global Healthcare...
-
Feb 18, 2020Revenue of $7.7 Billion Increased 2.3% Reported and 2.6% Organic
DUBLIN, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2020, which ended January 24, 2020. The company reported...
-
Feb 13, 2020Acquisition Will Accelerate Medtronic’s Strategy to Provide AI and Data Within Laparoscopic and Robotic Assisted Surgery
DUBLIN, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in...
-
Feb 10, 2020Giving Includes Medtronic Foundation Cash Donations to Partners and Product Donations from the Company Including Respirator Masks, Nitrile Gloves, Ventilators and Pulse Oximeters
DUBLIN, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it and the Medtronic Foundation are committing approximately $1.2M to...
-
Feb 4, 2020SPYRAL DYSTAL Study to Evaluate the Effects of RDN Using Fewer, Targeted Ablations to Achieve Meaningful Blood Pressure Reductions
DUBLIN, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it will begin enrollment in a pilot study evaluating the safety and efficacy of the Symplicity™ Spyral renal...
-
Feb 4, 2020
DUBLIN, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for the third quarter of fiscal year 2020 on Tuesday, February 18, 2020. A...
-
Jan 30, 2020Next Generation Technology Includes Features that Automatically Adjust to Patient Needs, and Offers Physicians Heart Failure Diagnostic Insights
DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable...
-
Jan 23, 2020Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal...
-
Jan 23, 2020Investigative Technology Designed to Interrupt Irregular Pathways in the Heart
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that it received approval from the U.S. Food and Drug Administration (FDA) to proceed with an investigational...